4//SEC Filing
Singh Shawn 4
Accession 0001415889-21-000020
CIK 0001411685other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 4:58 PM ET
Size
8.0 KB
Accession
0001415889-21-000020
Insider Transaction Report
Form 4
Singh Shawn
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Award
Stock Option (Right to Buy)
2020-12-30+300,000→ 300,000 totalExercise: $1.77Exp: 2030-12-30→ Common Stock (300,000 underlying) - Award
Common Stock
2020-12-31$0.45/sh+5,000$2,261→ 35,375 total
Holdings
- 26,234(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]Shares purchased under the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan on December 31, 2020 in a transaction exempt under Rule 16b-3(c).
- [F2]Twenty-five percent (25%) of the total number of shares shall be vested immediately on December 31, 2020 (the "Vesting Start Date") and 1/24th of the remaining number of shares shall vest monthly thereafter until all awarded shares are fully vested two (2) years after the Vesting Start Date.
Documents
Issuer
VistaGen Therapeutics, Inc.
CIK 0001411685
Entity typeother
Related Parties
1- filerCIK 0001412071
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 4:58 PM ET
- Size
- 8.0 KB